Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
Michael J. Carr, James Sun, Danielle K. DePalo, Luke D. Rothermel, Yun Song, Richard J. Straker, Kristin Baecher, Raphael J. Louie, Emma H. A. Stahlie, G. Paul Wright, Syeda Mahrukh Hussnain Naqvi, Young Chul Kim, Amod A. Sarnaik, Giorgos C. Karakousis, Michael Lowe, Keith A. Delman, Alexander C. J. van Akkooi, David W. Ollila, Frances A. Collichio, Jonathan S. Zager
Topics & Concepts
MedicineOncolytic virusInternal medicineRegimenConfidence intervalComplete responseSurgical oncologyMelanomaImmunotherapyStage (stratigraphy)OncologySurgeryGastroenterologyChemotherapyCancerCancer researchBiologyPaleontologyVirus-based gene therapy researchImmunotherapy and Immune ResponsesCAR-T cell therapy research